These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 10799606)
1. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other. Goulder PJ; Tang Y; Pelton SI; Walker BD J Virol; 2000 Jun; 74(11):5291-9. PubMed ID: 10799606 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53. Dorrell L; Willcox BE; Jones EY; Gillespie G; Njai H; Sabally S; Jaye A; DeGleria K; Rostron T; Lepin E; McMichael A; Whittle H; Rowland-Jones S Eur J Immunol; 2001 Jun; 31(6):1747-56. PubMed ID: 11385619 [TBL] [Abstract][Full Text] [Related]
3. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728 [TBL] [Abstract][Full Text] [Related]
5. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. Goulder PJ; Brander C; Annamalai K; Mngqundaniso N; Govender U; Tang Y; He S; Hartman KE; O'Callaghan CA; Ogg GS; Altfeld MA; Rosenberg ES; Cao H; Kalams SA; Hammond M; Bunce M; Pelton SI; Burchett SA; McIntosh K; Coovadia HM; Walker BD J Virol; 2000 Jun; 74(12):5679-90. PubMed ID: 10823876 [TBL] [Abstract][Full Text] [Related]
6. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. Masemola AM; Mashishi TN; Khoury G; Bredell H; Paximadis M; Mathebula T; Barkhan D; Puren A; Vardas E; Colvin M; Zijenah L; Katzenstein D; Musonda R; Allen S; Kumwenda N; Taha T; Gray G; McIntyre J; Karim SA; Sheppard HW; Gray CM; J Immunol; 2004 Oct; 173(7):4607-17. PubMed ID: 15383595 [TBL] [Abstract][Full Text] [Related]
7. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences. Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335 [TBL] [Abstract][Full Text] [Related]
9. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196 [TBL] [Abstract][Full Text] [Related]
10. Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1. van Baalen CA; Klein MR; Huisman RC; Dings ME; Kerkhof Garde SR; Geretti AM; Gruters R; van Els CA; Miedema F; Osterhaus AD J Gen Virol; 1996 Aug; 77 ( Pt 8)():1659-65. PubMed ID: 8760412 [TBL] [Abstract][Full Text] [Related]
11. Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones. Kurane I; West K; Tuazon CU; Zeng W; Ennis FA J Clin Virol; 2003 May; 27(1):38-43. PubMed ID: 12727527 [TBL] [Abstract][Full Text] [Related]
12. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals. Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229 [TBL] [Abstract][Full Text] [Related]
13. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection. Navis M; Schellens I; van Baarle D; Borghans J; van Swieten P; Miedema F; Kootstra N; Schuitemaker H J Immunol; 2007 Sep; 179(5):3133-43. PubMed ID: 17709528 [TBL] [Abstract][Full Text] [Related]
14. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection. Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287 [TBL] [Abstract][Full Text] [Related]
15. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response. Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386 [TBL] [Abstract][Full Text] [Related]
17. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. Goulder PJ; Sewell AK; Lalloo DG; Price DA; Whelan JA; Evans J; Taylor GP; Luzzi G; Giangrande P; Phillips RE; McMichael AJ J Exp Med; 1997 Apr; 185(8):1423-33. PubMed ID: 9126923 [TBL] [Abstract][Full Text] [Related]
19. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais. Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111 [TBL] [Abstract][Full Text] [Related]
20. Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1. Cohen WM; Bianco A; Connan F; Camoin L; Dalod M; Lauvau G; Ferriès E; Culmann-Penciolelli B; van Endert PM; Briand JP; Choppin J; Guillet JG J Virol; 2002 Oct; 76(20):10219-25. PubMed ID: 12239297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]